1 | Anti-von Willebrand Factor Nanobody, Caplacizumab (Synonym: D11160) | 2件: Caplacizumab Caplacizumab, Von Willebrand factor human | 1件: D11160
D11160
| 1件: VWF VWF 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 |
2 | Anti-von Willebrand Factor Nanobody, INN = Caplacizumab (Synonym: D11160) | 2件: Caplacizumab Caplacizumab, Von Willebrand factor human | 1件: D11160
D11160
| 1件: VWF VWF 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 |
3 | CAPLACIZUMAB (Synonym: D11160) | 1件: Caplacizumab Caplacizumab | 1件: D11160
D11160
| 1件: VWF VWF 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 |
4 | Caplacizumab (ALX-0081) (Synonym: D11160) | 1件: Caplacizumab Caplacizumab | 1件: D11160
D11160
| 1件: VWF VWF 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 |
5 | Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) (Synonym: D11160) | 2件: Caplacizumab Caplacizumab, Von Willebrand factor human | 1件: D11160
D11160
| 1件: VWF VWF 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 |
6 | Caplacizumab (an anti-von Willebrand Factor Nanobody) (Synonym: D11160) | 2件: Caplacizumab Caplacizumab, Von Willebrand factor human | 1件: D11160
D11160
| 1件: VWF VWF 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 |